-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – KNK-003 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KNK-003 in Myelodysplastic Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KNK-003 in Myelodysplastic Syndrome Drug Details: KNK-003 (SAR-445419) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KNK-003 in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KNK-003 in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KNK-003 in Chronic Myelocytic Leukemia (CML,...
-
Product Insights
Arcadis Ost I
Arcadis Ost I is an offshore wind project located in Baltic Sea, Germany. The project is owned by Parkwind NV and is developed by KNK Wind GmbH; Parkwind NV. The project is currently under construction. Empower your strategies with our Arcadis Ost I report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – KNK-003
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry KNK-003 Drug Details KNK-003 is under development for the treatment of relapsed, refractory acute...